You are here

Eli Lilly

New Alzheimer's prevention trial receives $74.5 million NIH grant

Drugs.com

Sun, 11/17/24 - 09:22 pm

Alzheimer's disease

clinical trials

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

Lilly sues US agency over blocking of drug-rebate program

MSN/Reuters

Fri, 11/15/24 - 11:08 am

Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free

Pharma Live

Thu, 11/14/24 - 11:21 am

Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’

Pharma Voice

Tue, 11/12/24 - 09:49 am

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

Pharma Voice

Thu, 11/7/24 - 11:12 am

Vertex Pharmacuticals

Alpine Immune Sciences

Mariana Oncology

Fusion Pharmaceuticals

Longboard Pharmaceuticals

Aliada Therapeutics

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Beckers Hospital Review

Wed, 11/6/24 - 08:01 pm

States slow to cover GLP-1s for weight loss

Axios

Wed, 11/6/24 - 11:37 am

Lilly shares fall as obesity drug sales miss forecasts

BioPharma Dive

Wed, 10/30/24 - 11:52 am

Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's

First Word Pharma

Mon, 10/28/24 - 06:24 pm

Crohn's Disease

clinical trials

J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups

Fierce Pharma

Fri, 10/25/24 - 11:43 am

plaque psoriasis

atopic dermatits

How Lilly is building a brand people trust

Medical Marketing and Media

Thu, 10/24/24 - 08:20 pm

Weight-loss drugs didn't curb health costs within two years

Reuters

Thu, 10/24/24 - 11:11 am

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Reuters

Thu, 10/24/24 - 09:53 am

Lilly's Alzheimer's drug gets UK nod, but no NHS funding

Pharmaphorum

Wed, 10/23/24 - 11:26 am

Alzheimer's disease

Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'

Fierce Pharma

Tue, 10/22/24 - 11:32 pm

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

Pharma Voice

Mon, 10/21/24 - 09:37 am

On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study

Fierce Pharma

Tue, 10/15/24 - 10:15 am

Crohn's Disease

clinical trials

FDA, facing pressure, to review position on Zepbound, Mounjaro shortage

BioPharma Dive

Mon, 10/14/24 - 11:17 pm

Lilly picks UK for first European Gateway Lab as part of $364M investment plan

Fierce Biotech

Mon, 10/14/24 - 10:28 am

Pages